Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Begins Device User Fee Collection; Appropriations Still In Doubt

This article was originally published in The Silver Sheet

Executive Summary

MEDICAL DEVICE USER FEE PERFORMANCE GOALS may not be met if promised increases in appropriations for premarket activities are not provided, FDA officials warn. Nevertheless, the Center for Devices and Radiological Health is committed to making progress on its performance goals with available funds and plans to hire about 40 device review staffers over the next two years. CDRH is focusing on educating manufacturers on how to follow new user fee payment procedures to avoid review delays. New guidance for firms eligible for small business discounts is due out this summer

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036077

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel